Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Compounds for schizophrenia, anxiety, depression, etc. revealed in patents

July 18, 2005

New agents for diabetes and related conditions reported in recent patents

July 18, 2005

New antibacterial transcription inhibitors emerge from French R&D

July 15, 2005

New agents for gastrointestinal disorders described in recent patent literature

July 15, 2005

Cysteine protease inhibitors in early development at Celera

July 14, 2005

HIV replication inhibitors from Janssen

July 14, 2005

New treatments for cancer reported in patent literature

July 13, 2005

Immunomodulators claimed in recent patents

July 13, 2005

Novel agents for the treatment of neurological disorders in early development

July 12, 2005

Companies patent new therapies for depression, psychosis, etc.

July 12, 2005

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...